5-Aza-2'-deoxycytidine may influence the proliferation and apoptosis of cervical cancer cells via demethylation in a dose- and time-dependent manner

Genetics and Molecular Research

Volumn 12, Issue 1, 2013, Pages 312-318

  Yao, T T ^a   Mo, S M ^b   Liu, L Y ^a   Lu, H W ^a   Huang, M L ^a   Lin, Z Q ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Macao Special Administrative Region of the People's Republic of China   (China)

Author keywords

5 Aza 2' deoxycytidine; APAF 1; Cervical cancer; DNA methylation; RASSF1A

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; APAF1 PROTEIN, HUMAN; AZACITIDINE; DRUG DERIVATIVE; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APAF 1 GENE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMETHYLATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; RASSF1A GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL GROWTH; DNA METHYLATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; AZACITIDINE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84878798822     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.February.4.5     Document Type: Article

References (21)

1. Andreev DE, Dmitriev SE, Zinovkin R, Terenin IM, et al. (2012). The 5' untranslated region of Apaf-1 mRNA directs translation under apoptosis conditions via a 5' end-dependent scanning mechanism. FEBS Lett. 586: 4139-4143.
2. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, et al. (2001). Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93: 691-699.
3. Christoph F, Kempkensteffen C, Weikert S, Kollermann J, et al. (2006). Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. Br. J. Cancer 95: 1701-1707.
4. Chu SH, Ma YB, Feng DF, Zhang H, et al. (2012). Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells. Mol. Med. Report. 5: 138-141.
5. Dammann R, Takahashi T and Pfeifer GP (2001). The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 20: 3563-3567.
6. Dreijerink K, Braga E, Kuzmin I, Geil L, et al. (2001). The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 98: 7504-7509.
7. Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, et al. (1997). Role of estrogen receptor gene demethylation and DNA methyltransferase. DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells. J. Biol. Chem. 272: 32260-32266.
8. Hassler MR, Klisaroska A, Kollmann K, Steiner I, et al. (2012). Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma. Biochimie 94: 2297-2307.
9. Kuzmin I, Gillespie JW, Protopopov A, Geil L, et al. (2002). The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res. 62: 3498-3502.
10. Kuzmin I, Liu L, Dammann R, Geil L, et al. (2003). Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res. 63: 1888-1893.
11. Kwong J, Lo KW, To KF, Teo PML, et al. (2002). Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res. 8: 131-137.
12. Lee MG, Kim HY, Byun DS, Lee SJ, et al. (2001). Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res. 61: 6688-6692.
13. Liu L, Yoon JH, Dammann R and Pfeifer GP (2002). Frequent hypermethylation of the RASSF1A gene in prostate cancer. Oncogene 21: 6835-6840.
14. Melzer IM, Fernandez SB, Bosser S, Lohrig K, et al. (2012). The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential. Cell Death. Differ. 19: 1435-1445.
15. Menschikowski M, Platzbecker U, Hagelgans A, Vogel M, et al. (2012). Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells. BMC Cancer 12: 576.
16. Montenegro MF, Saez-Ayala M, Pinero-Madrona A, Cabezas-Herrera J, et al. (2012). Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation. PLoS One 7: e52231.
17. Niimi S, Arakawa-Takeuchi S, Uranbileg B, Park JH, et al. (2012). Cdc6 protein obstructs apoptosome assembly and consequent cell death by forming stable complexes with activated Apaf-1 molecules. J. Biol. Chem. 287: 18573-18583.
18. Ozdemir F, Altinisik J, Karateke A, Coksuer H, et al. (2012). Methylation of tumor suppressor genes in ovarian cancer. Exp. Ther. Med. 4: 1092-1096.
19. Sankaranarayanan R and Ferlay J (2006). Worldwide burden of gynaecological cancer: the size of the problem. Best. Pract. Res. Clin. Obstet. Gynaecol. 20: 207-225.
20. Vos MD, Ellis CA, Bell A, Birrer MJ, et al. (2000). Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275: 35669-35672.
21. Wu Y, Meng L, Wang H, Xu Q, et al. (2006). Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis. Oncol. Rep. 16: 625-629.